The global Orthobiologics market size is expected to be worth around US$ 20.2 billion by 2030, according to a new report by Vision Research Reports.
The global Orthobiologics market size was valued at US$ 15.0 billion in 2020 and is anticipated to grow at a CAGR of 17.5% during forecast period 2021 to 2030.
The orthobiologics industry trends is predominantly driven by the increasing orthopedic disease and musculoskeletal disease burden globally. Moreover, emerging technological innovations in biomaterials, used in the production of orthobiologics are presumed to accelerate the market demand over the forecast period and will help grow the competition among the key players, particularly in U.S. These predominantly include modifications in graft designs, advent of recombinant biologic agents, stem cell therapy and cultured tissue scaffolds.
These advancements are accompanied with the benefits such as enhanced biocompatibility, reduced surgical time and smaller incisions. Furthermore, these novel solutions are presumed to efficiently reduce the recurrence of post-operative complications, which in turn is expected to boost the orthobiologics device market during the forecast period.
In the product segment, viscosupplementation held the dominant share of orthobiologics market in 2020. The substantial share is attributed to the high adoption of these products as a consequence of wide range availability and unprecedented adoption in diseases such as osteoarthritis, hip degenerative joint disease.
The high adoption rate is presumed to be a consequence of the benefits associated with viscosupplementation. These benefits include better knee movement, pain reduction, less-invasive, and fewer side effects. It is also presumed to be a result of high demand for minimally invasive operative procedures leading to high acceptance by the patient population base.
spinal fusion accounted for a majority share of over 50.0% in the application segment. The dominant share can be attributed to the consistent penetration of demineralized bone matrices, bone morphogenetic proteins, autografts and allografts in spinal fusion surgeries owing to its ability to provide high bone stability and rapid bone healing thereby improving long-term spinal disorders.
Other benefits of orthobiological products in spinal fusion, such as rapid stimulation of cells to initiate bone formation, reduced hospital stay duration, and visits, are believed to be responsible for garnering a larger share in the application segment. The substantial share attained by orthobiologics is also believed to be a consequence of the presence of third-party insurers and reimbursement available for fusion enhancement products thus triggering growth.
hospitals held a dominant share in the end-use segment. Increasing adoption of orthobiological products in a wide range of spinal and reconstructive surgeries performed in hospitals is a key factor attributed to the segment share dominance. Moreover, specialized patient care and easy availability of a wide range of orthobiologics in hospitals are anticipated to be a segment growth factor.
In addition, high patient turnaround, frequent readmissions, and large procedure volumes contributed toward the segment share. Moreover, the supportive infrastructure facilitates accurate operative procedures, which is further anticipated to raise the growth potential.
North America held a substantial share of the global market in 2020. The share acquired by this region can be attributed to the presence of the majority of the prominent players involved in promoting quality care and undertaking new product development strategies. In addition, reimbursement policies available for soft tissue healing and fusion enhancement products are also significantly contributing toward the regional share.
The Asia Pacific regional space is expected to grow at an exponential rate throughout the forecast period. This growth is mainly due to the rising healthcare spending and disposable income and physician awareness levels pertaining to the benefits of these products.
In addition, the heightening quality of healthcare infrastructure is further anticipated to present the market with lucrative growth opportunities across this region. Moreover, increasing product launch across this region aside from growing competition among the key industry players is also one of the significant factors contributing toward the growth.
For instance, in January 2020, Bioventus launched DUROLANE, hyaluronic acid-based single-injection for joint-fluid osteoarthritis treatment, in Taiwan. This product launch led to a greater geographical presence of the company and also fueled the product penetration of orthobiological products in Asia Pacific region.
Bone Biologics, Corp.; Medtronic; Bioventus LLC; Pioneer Surgical Technology; Smith & Nephew plc; Stryker Corporation; DePuy Synthes, Inc.; Genzyme; Osiris Therapeutics, Inc.; Globus Medical; Wright Medical Technology; Orthofix, Inc.; NuVasive, Inc.; Zimmer Biomet; Anthrex
Global Orthobiologics Product Outlook
Demineralized Bone Matrix(DBM)
Bone Morphogenetic Protein (BMP)
Synthetic Bone Substitutes
Stem Cell Therapy
Global Orthobiologics Application Outlook
Global Orthobiologics End-use Outlook
Orthobiologics Regional Outlook
Middle East and Africa
The Orthobiologics market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Orthobiologics market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Orthobiologics market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Orthobiologics market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Orthobiologics market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Orthobiologics capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Orthobiologics by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Orthobiologics market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Orthobiologics market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Orthobiologics market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Orthobiologics industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
The Orthobiologics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Orthobiologics market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Orthobiologics market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Orthobiologics market. These factors have benefited the growth of the global market for Orthobiologics. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Orthobiologics. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Orthobiologics are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
To strategically profile the key players and comprehensively analyze their growth strategies.
Healthcare Testing, Inspection, And Certification Outsourcing Market (By Services: Testing, Inspection, Certification; By Type) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...
Pupillometer Market (By Mobility: Table-top, Hand-held; By Type: Video, Digital; By End-use: Hospitals, Eye Clinics; By Application: Ophthalmology, Oncology) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...
North America And Europe Preclinical Medical Device Testing Services Market (By Service: Biocompatibility Tests, Chemistry Test, Microbiology & Sterility Testing) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...
Cell Banking Outsourcing Market (By Type: Master Cell Banking, Working Cell Banking, Viral Cell Banking; By Cell Type; By Phase) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...
Biologics Contract Development Market (By Source: Mammalian, Microbial; By Product Service Type; By Indication: Oncology, Immunological Disorders) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030Read more...